Browsing by Author Briassoulis, E.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 1 to 17 of 17
TitleAuthor(s)Issue date???itemlist.???
Clear evidence that long-term, low-dose tamoxifen treatment can induce ocular toxicity. A prospective study of 63 patientsPavlidis, N. A.; Petris, C.; Briassoulis, E.; Klouvas, G.; Psilas, C.; Rempapis, J.; Petroutsos, G.24-Nov-2015-
Dose-dense sequential chemotherapy with epirubicin and paclitaxel in advanced breast cancerRazis, E.; Dimopoulos, A. M.; Bafaloukos, D.; Papadimitriou, C.; Kalogera-Fountzila, A.; Kalofonos, H.; Briassoulis, E.; Samantas, E.; Keramopoulos, A.; Pavlidis, N.; Kosmidis, P.; Fountzilas, G.24-Nov-2015-
Dose-dense sequential chemotherapy with epirubicin and paclitaxel versus the combination, as first-line chemotherapy, in advanced breast cancer: a randomized study conducted by the Hellenic Cooperative Oncology GroupFountzilas, G.; Papadimitriou, C.; Dafni, U.; Bafaloukos, D.; Skarlos, D.; Moulopoulos, L. A.; Razis, E.; Kalofonos, H. P.; Aravantinos, G.; Briassoulis, E.; Papakostas, P.; Abela, K.; Gogas, E.; Kosmidis, P.; Pavlidis, N.; Dimopoulos, M. A.24-Nov-2015-
Evaluation of 6 Tumor-Markers in Patients with Carcinoma of Unknown PrimaryPavlidis, N.; Kalefezra, J.; Briassoulis, E.; Skarlos, D.; Kosmidis, P.; Saferiadis, K.; Bairaktari, E.; Bafaloukos, D.; Maravegias, A.; Theoharis, D.; Fountzilas, G.24-Nov-2015-
Evaluation of six tumor markers in patients with carcinoma of unknown primaryPavlidis, N.; Kalef-Ezra, J.; Briassoulis, E.; Skarlos, D.; Kosmidis, P.; Saferiadis, K.; Bairaktari, E.; Bafaloukos, D.; Maravegias, A.; Theoharis, D.; et al.,24-Nov-2015-
Fluorouracil and leucovorin with or without interferon alfa-2a as adjuvant treatment, in patients with high-risk colon cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology GroupFountzilas, G.; Zisiadis, A.; Dafni, U.; Konstantaras, C.; Hatzitheoharis, G.; Papavramidis, S.; Bousoulegas, A.; Basdanis, G.; Giannoulis, E.; Dokmetzioglou, J.; Katsohis, C.; Nenopoulou, E.; Karvounis, N.; Briassoulis, E.; Aravantinos, G.; Kosmidis, P.; Skarlos, D.; Pavlidis, N.24-Nov-2015-
Fluorouracil and leucovorin with or without interferon alfa-2b in advanced colorectal cancer: analysis of a prospective randomized phase III trial. Hellenic Cooperative Oncology GroupKosmidis, P. A.; Tsavaris, N.; Skarlos, D.; Theocharis, D.; Samantas, E.; Pavlidis, N.; Briassoulis, E.; Fountzilas, G.24-Nov-2015-
Is interferon-a an active agent in Castleman's disease?Pavlidis, N. A.; Briassoulis, E.; Klouvas, G.; Bai, M.24-Nov-2015-
Is the combination of 5-fluorouracil and folinic acid effective in advanced gastric carcinoma? Results of a pilot study and review of the literaturePavlidis, N.; Nicolaides, C.; Klouvas, G.; Briassoulis, E.24-Nov-2015-
Overexpression of C-myc, Ras and C-erbB-2 oncoproteins in carcinoma of unknown primary originPavlidis, N.; Briassoulis, E.; Bai, M.; Fountzilas, G.; Agnantis, N.24-Nov-2015-
p53/MDM-2 immunohistochemical expression correlated with proliferative activity in different subtypes of human sarcomas: a ten-year follow-up studyStefanou, D. G.; Nonni, A. V.; Agnantis, N. J.; Athanassiadou, S.; Briassoulis, E.; Pavlidis, N.24-Nov-2015-
Paclitaxel in combination with carboplatin or gemcitabine for the treatment of advanced head and neck cancerFountzilas, G.; Athanassiades, A.; Kalogera-Fountzila, A.; Samantas, E.; Bacoyiannis, C.; Briassoulis, E.; Pavlidis, N.; Kosmidis, P.; Skarlos, D.24-Nov-2015-
Prognostic factors influencing complete response to treatment and survival of patients with nasopharyngeal cancerKalogera-Fountzila, A.; Kosmidis, P.; Bacoyiannis, C.; Nicolaou, A.; Samantas, E.; Briassoulis, E.; Pavlidis, N.; Skarlos, D.; Daniilidis, J.; Fountzilas, G.24-Nov-2015-
Randomized comparison of early versus late hyperfractionated thoracic irradiation concurrently with chemotherapy in limited disease small-cell lung cancer: A randomized phase II study of the Hellenic Cooperative Oncology Group (HeCOG)Skarlos, D. V.; Samantas, E.; Briassoulis, E.; Panoussaki, E.; Pavlidis, N.; Kalofonos, H. P.; Kardamakis, D.; Tsiakopoulos, E.; Kosmidis, P.; Tsavdaridis, D.; Tzitzikas, J.; Tsekeris, P.; Kouvatseas, G.; Zamboglou, N.; Fountzilas, G.24-Nov-2015-
Second malignancies following treatment for Hodgkin's disease: a Greek experienceEconomopoulos, T.; Stathakis, N.; Alexopoulos, C.; Pavlidis, N.; Constantinidou, M.; Briassoulis, E.; Papageorgiou, E.; Dervenoulas, J.; Pappa, V.; Vaslamatzis, M.; et al.,24-Nov-2015-
Subsets of tumors responsive to cisplatin or carboplatin combinations in patients with carcinoma of unknown primary site. A Hellenic Cooperative Oncology Group StudyPavlidis, N.; Kosmidis, P.; Skarlos, D.; Briassoulis, E.; Beer, M.; Theoharis, D.; Bafaloukos, D.; Maraveyas, A.; Fountzilas, G.24-Nov-2015-
The Value of Ca-125 Determination in the Serum of Patients with Non-Hodgkins-Lymphomas - a Preliminary-ReportPavlidis, N. A.; Bairaktari, E.; Kalefezra, J.; Nicolaides, C.; Briassoulis, E.; Seferiadis, C.; Fountzilas, G.24-Nov-2015-